AJ

Abhishek Jain

Active Director Director DIN 10528511
DIN 10528511 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Abhishek Jain

Data last updated:

Abhishek Jain is a Director at Impetis Biosciences Limited (since 2024). The company operates in Pharma. Impetis Biosciences Limited reported revenue of ₹1.48 Cr (FY 2026).

DIN 10528511
Primary Designation Director
Industry Pharma
First Appointment 04 Mar 2024
Oldest Company Age 9 yrs
Largest company Impetis Biosciences Limited · ₹1.48 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Impetis Biosciences Limited U74999MH2017PLC295474
Director04 Mar 20242017₹1.48 Cr (FY 2026)Active

Board colleagues of Abhishek Jain

NameDINCompanyDesignation
Shaurya Nemish Mehta05129792Impetis Biosciences LimitedAdditional Director
Tarun Dayal Bhojwani09809233Impetis Biosciences LimitedDirector

Directorship timeline

Open interactive timeline →
Impetis Biosciences Limited
Premium access

Shareholding and investment profile for Abhishek Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Jain

Abhishek Jain currently holds 1 directorship: Impetis Biosciences Limited (Director, since 04 Mar 2024, revenue ₹1.48 Cr (FY 2026)).

Abhishek Jain was first appointed on 04 Mar 2024 as Director at Impetis Biosciences Limited.

The current boards of Abhishek Jain's companies include Shaurya Nemish Mehta (Impetis Biosciences Limited), Tarun Dayal Bhojwani (Impetis Biosciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available